Dr. Peter F. Keenan III, MD

Dr. Keenan practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Keenan's NPI, 1699068601, was assigned on May 24, 2011. Dr. Keenan graduated from Boston University School Of Medicine in 2011. Dr. Keenan holds California license 140040.

Dr. Keenan's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Keenan's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Keenan is also affiliated with UCI Health - Lakewood. The medical group on file is Vituity. Dmand AI also links Dr. Keenan to 1 more hospital and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keenan practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Keenan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Keenan is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Keenan's licenses on file in 3 states: California, Texas and New York.

CMS data shows 980 Medicare services from Dr. Keenan across 7 procedure codes in 2024, for 502 Medicare patients. Medicare paid $82,112 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 502 Medicare patients who saw Dr. Keenan in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keenan's median patient age at 62, with 57% women.

In 2024, Dr. Keenan wrote 261 Medicare Part D claims for 167 patients. 95% of them were for generic drugs. CMS names the drug for 139 of them, across 6 drugs with 11 or more claims each, at $1,119 in total drug cost. In 2023, CMS named 178 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Keenan for performance year 2024, reported as part of a group. Dr. Keenan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Keenan from 3 drug and device companies in 2017. Food and beverage make up the largest share, 100% of the total. Penumbra, Inc. paid the most, $150.

Dr. Keenan graduated from Boston University School Of Medicine in 2011.